PATRICK J. HERON

Profile

First Name

: PATRICK

Middle Name

: J.

Last Name

: HERON

Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER
FRAZIER LIFE SCIENCES VIII, L.P.
NATHAN EVERY, N/A FHM LIFE SCIENCES VIII, L.L.C., N/A FHM LIFE SCIENCES VIII, L.P., ALAN D. FRAZIER, N/A FRAZIER MANAGEMENT, L.L.C., NADER NAINI, JAMES N. TOPPER
PROMOTER
FRAZIER HEALTHCARE GROWTH BUYOUT FUND VIII, L.P.
NATHAN EVERY, N/A FHM GROWTH BUYOUT VIII, L.L.C., N/A FHM GROWTH BUYOUT VIII, L.P., ALAN D. FRAZIER, N/A FRAZIER MANAGEMENT, L.L.C., BEN MAGNANO, BRIAN MORFITT, NADER NAINI, JAMES N. TOPPER
PROMOTER
FRAZIER HEALTHCARE GROWTH BUYOUT AFFILIATES VIII, L.P.
NATHAN EVERY, N/A FHM GROWTH BUYOUT VIII, L.L.C., N/A FHM GROWTH BUYOUT VIII, L.P., ALAN D. FRAZIER, N/A FRAZIER MANAGEMENT, L.L.C., BEN MAGNANO, BRIAN MORFITT, NADER NAINI, JAMES N. TOPPER
DIRECTOR
ITERUM THERAPEUTICS LTD
BRENTON K. AHRENS, LOUISE BARRETT, MARK CHIN, MICHAEL DUNNE, MICHAEL W. DUNNE, PAUL R. EDICK, COREY N. FISHMAN, JAMES I. HEALY, PATRICK HERON, ROBERT HOPFNER, RONALD M. HUNT, DAVID KELLY, DAVID I. KELLY, SHAHZAD MALIK, JUDITH M. MATTHEWS, TRACY SAXTON, JEFF SCHAFFNIT
EXECUTIVE OFFICER
FRAZIER LIFE SCIENCES IX, L.P.
DANIEL J. ESTES, N/A FHMLS IX, L.L.C., N/A FHMLS IX, L.P., N/A FRAZIER MANAGEMENT, L.L.C., JAMES N. TOPPER
PROMOTER
FRAZIER HEALTHCARE GROWTH BUYOUT AFFILIATES IX, L.P.
NATHAN EVERY, N/A FHM GROWTH BUYOUT IX, L.L.C., N/A FHM GROWTH BUYOUT IX, L.P., ALAN FRAZIER, N/A FRAZIER MANAGEMENT, L.L.C., BEN MAGNANO, BRIAN MORFITT, NADER NAINI, JAMES N. TOPPER
PROMOTER
FRAZIER HEALTHCARE GROWTH BUYOUT FUND IX, L.P.
NATHAN EVERY, N/A FHM GROWTH BUYOUT IX, L.L.C., N/A FHM GROWTH BUYOUT IX, L.P., ALAN FRAZIER, N/A FRAZIER MANAGEMENT, L.L.C., BEN MAGNANO, BRIAN MORFITT, NADER NAINI, JAMES N. TOPPER
PROMOTER
FRAZIER HEALTHCARE GROWTH BUYOUT FUND IX PV, L.P.
NATHAN EVERY, N/A FHM GROWTH BUYOUT IX, L.L.C., N/A FHM GROWTH BUYOUT IX, L.P., ALAN FRAZIER, N/A FRAZIER MANAGEMENT, L.L.C., BEN MAGNANO, BRIAN MORFITT, NADER NAINI, JAMES N. TOPPER
DIRECTOR
IMAGO BIOSCIENCES, INC.
ROBERT BALTERA, LAURA G. EICHORN, DENNIS HENNER, DENNIS J. HENNER, DENNIS` J. HENNER, PATRICK HERON, DINA CHAYA MOGHRABI, HUGH Y. RIENHOFF, HUGH Y. RIENHOFF, JR., ALAN SACHS, HARISH SOUNDARARAJAN
DIRECTOR
ITERUM THERAPEUTICS BERMUDA LTD
BRENTON K. AHRENS, LOUISE BARRETT, MARK CHIN, MICHAEL DUNNE, COREY N. FISHMAN, JAMES I. HEALY, RONALD M. HUNT, DAVID KELLY, SHAHZAD MALIK, JUDITH M. MATTHEWS
DIRECTOR
ITERUM THERAPEUTICS PLC
BRENTON K. AHRENS, LOUISE BARRETT, MARK CHIN, MICHAEL DUNNE, MICHAEL W. DUNNE, PAUL R. EDICK, COREY N. FISHMAN, JAMES I. HEALY, PATRICK HERON, ROBERT HOPFNER, RONALD M. HUNT, DAVID KELLY, DAVID I. KELLY, SHAHZAD MALIK, JUDITH M. MATTHEWS, TRACY SAXTON, JEFF SCHAFFNIT
DIRECTOR
ITERUM THERAPEUTICS US LTD
BRENTON K. AHRENS, LOUISE BARRETT, MARK CHIN, MICHAEL DUNNE, COREY N. FISHMAN, JAMES I. HEALY, RONALD M. HUNT, DAVID KELLY, SHAHZAD MALIK, JUDITH M. MATTHEWS
DIRECTOR
ITERUM THERAPEUTICS US HOLDING LTD
BRENTON K. AHRENS, LOUISE BARRETT, MARK CHIN, MICHAEL DUNNE, COREY N. FISHMAN, JAMES I. HEALY, RONALD M. HUNT, DAVID KELLY, SHAHZAD MALIK, JUDITH M. MATTHEWS
DIRECTOR
ITERUM THERAPEUTICS INTERNATIONAL LTD
BRENTON K. AHRENS, LOUISE BARRETT, MARK CHIN, MICHAEL DUNNE, COREY N. FISHMAN, JAMES I. HEALY, RONALD M. HUNT, DAVID KELLY, SHAHZAD MALIK, JUDITH M. MATTHEWS
DIRECTOR
MIRUM PHARMACEUTICALS, INC.
TIBA AYNECHI, ERIC BJERKHOLT, LAURA BREGE, LON CARDON, IAN CLEMENTS, SUSAN DUBE, WILLIAM C. FAIREY, LAURENT FISCHER, MICHAEL GREY, MICHAEL G. GREY, PATRICK HERON, JONATHAN LEFF, LARA LONGPRE, ED MATHERS, EDWARD T. MATHERS, NIALL O-DONNELL, CHRIS PEETZ, CHRISTOPHER PEETZ, PETER RADOVICH, SAIRA RAMASASTRY, EDWIN JONATHAN TUCKER, PAMELA VIG, TIMOTHY WALBERT
EXECUTIVE OFFICER
FRAZIER LIFE SCIENCES XI, L.P.
DANIEL J. ESTES, JAMES N. TOPPER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-03-18
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2022-03-15 
2020-12-30
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-12-22 
2020-11-20
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2020-11-12 
2020-07-07
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2020-07-02 
2020-06-12
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2020-06-05 
2020-01-31
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2020-01-21 
2020-01-31
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2020-01-21 
2020-01-31
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2020-01-21 
2020-01-31
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2020-01-21 
2020-01-31
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2020-01-21 
2019-03-28
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2019-03-15 
2018-04-10
D/A
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
Equity 
2017-12-15 
2018-04-09
D/A
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2017-12-15 
2018-04-09
D/A
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2017-12-15 
2018-03-02
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-05-18 
2017-11-01
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2017-10-31 
2017-06-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-05-18 
2016-12-30
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-11-18 
2016-03-23
D/A
Link
PRIVATE EQUITY FUND 
 
NOT APPLICABLE 
 
2015-11-03 
2016-03-23
D
Link
PRIVATE EQUITY FUND 
 
NOT APPLICABLE 
 
2016-03-23 
2016-01-12
D/A
Link
PRIVATE EQUITY FUND 
 
NOT APPLICABLE 
 
2015-11-03 
2015-10-29
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2015-10-15